FACTORS AFFEKTING THE DEVELOPMENT OF COGNITIVE FYNCTION IN PERSONS WHO SURVIVED COVID-19
Abstract
The COVID-19 pandemic has shown that this is a disease that affects almost all organs and systems. At the same time, the problem of damage to the nervous system that leads to serious consequences in the form of various vascular inflammation and degenerative pathologies (stroke, encephalitis, polyneuropathy) of the brain and peripheral nerves are increasing. The question of the origin of cognitive impairment at a young age in people who did not have any problems with intellectual functions before COVID-19 is more complicated. This issue is closely related to the issue of the pathogenesis of damage to the nervous system in COVID-19. At the same time, the cognitive function of a person also closely depends on the emotional state, educational qualification, gender and age. These factors are not well covered in the literature. With this in mind, we conducted this study.
Keywords
Cognitive impairment, anxiety-depressive devices, COVID-19How to Cite
References
1.Almeria M., Cejudo J.C., Sotoca J. et al. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020;9:100163.DOI:10.1016/j.bbih.2020.100163.
2.DosSantos MF, Devalle E, Aran V, et al. Neuromechanisms of SARS-CoV-2: A Review. Front Neuroanat. 2020 Jun 16;14:37. doi: 10.3389/fnana.2020.00037. eCollection 2020.
Bohmwald K, Galvez NMS, Rios M, Kalergis AM. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018 Oct 26;12:386. doi: 10.3389/fncel.2018.00386. eCollection 2018.
Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005 Aug 1;202(3):415-24. doi: 10.1084/jem.20050828. Epub 2005 Jul 25.
Varatharaj A, Thomas N, Ellul MA, et al. Neurological and neuropsychiatric complica- tions of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020 Oct;7(10):875-82. doi: 10.1016/S2215- 0366(20)30287-X. Epub 2020 Jun 25.
Pinna P, Grewal P, Hall JP, et al. Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline. J Neurol Sci. 2020 Aug 15;415:116969. doi: 10.1016/j.jns.2020.116969. Epub 2020 Jun 3. 10. Helms J, Kremer S, Merdji H. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020 Jun 4;382(23):2268-70. doi:
Chaumont H, San-Galli A, Martino F, et al. Mixed central and peripheral nervous sys- tem disorders in severe SARS-CoV-2 infection. J Neurol. 2020 Nov;267(11):3121-7. doi: 10.1007/s00415-020-09986-y. Epub 2020 Jun 12. 12. Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611-27. doi: 10.1016/S2215-0366(20)30203-0.
Mazza M.G., Palladini M., De Lorenzo R. et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun Health. 2021;94:138–147.DOI:10.1016/j.bbi.2021.02.021.
Остроумова ТМ, Черноусов ПА, Кузнецов ИВ. Когнитивные нарушения у пациентов, перенесших COVID-19. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):126–130.
License
Copyright (c) 2023 Gafurov Bakhtiyor Gafurovich
This work is licensed under a Creative Commons Attribution 4.0 International License.